Daily 16:8 Versus Weekly 5:2 Intermittent Fasting for Weight Loss and Metabolic Health: A Randomized Controlled Trial
Related Experiment Video
Updated: Oct 30, 2026

Assessment of the Metabolic Effects of Isocaloric 2:1 Intermittent Fasting in Mice
Published on: November 27, 2019
Hyunji Kim1, WonYoung Yun1, Jihye Han1
1Department of Food Science & Nutrition, The Catholic University of Korea, Bucheon, Republic of Korea.
Objective:
This study compared the effects of 16:8 and 5:2 intermittent fasting on body weight, metabolic outcomes, and temporal response patterns in adults with overweight or obesity.
Methods:
In this open-label randomized trial, 68 women with overweight or obesity were assigned to either a 16:8 regimen or a 5:2 regimen using a fasting-mimicking diet on fasting days for 4 weeks. Primary outcomes were changes in body weight and body composition; secondary outcomes included waist circumference, blood pressure, dietary intake, and glycemic metrics.
Results:
Across both groups, body weight decreased by 2.7 kg (95% CI -2.9 to -2.4), fat mass by 1.7 kg (-1.9 to -1.5), and muscle mass by 0.6 kg (-0.7 to -0.4). Weight and fat mass reductions were greater over time in the 5:2 group than in the 16:8 group, whereas muscle mass changes were similar. Waist circumference and blood pressure decreased significantly, with no between-group differences. Both regimens reduced eating window duration, energy intake, mean and peak glucose levels, and time spent in hyperglycemia.
Conclusions:
Both regimens improved body weight and metabolic outcomes over 4 weeks. Despite similar overall effectiveness, the regimens exhibited distinct temporal response patterns, suggesting that temporal dynamics may inform individualized intermittent fasting strategies.
Trial Registration:
Clinical Research Information Service (cris.nih.go.kr) identifier: KCT0010806.
Related Concept Videos
Metabolic States of the Body: Fasting and Starvation
Energy Balance
Metabolic States of the Body: The Postabsorptive State
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
Bioavailability Study Design: Healthy Subjects Versus Patients